Cellular mechanism and arrhythmogenic potential of T-wave alternans in the Brugada syndrome

Journal of Cardiovascular Electrophysiology

Volumn 19, Issue 3, 2008, Pages 301-308

  Fish, Jeffrey M ^a   Antzelevitch, Charles ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Alternans; Arrhythmia; Electrocardiogram; Sudden cardiac death; T wave

Indexed keywords

VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; BRUGADA SYNDROME; CONTROLLED STUDY; DOG; ELECTROCARDIOGRAPHY; EXPERIMENTAL MODEL; HEART MUSCLE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; QT INTERVAL; RISK FACTOR; STATISTICAL ANALYSIS; T WAVE;

ANIMALS; ARRHYTHMIAS, CARDIAC; BODY SURFACE POTENTIAL MAPPING; BRUGADA SYNDROME; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOGS; FEMALE; HEART CONDUCTION SYSTEM; MALE; MYOCYTES, CARDIAC;

EID: 39749084614     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2007.01025.x     Document Type: Article

References (35)

1. Antzelevitch C, Brugada P, Brugada J, Brugada R : The Brugada Syndrome: From Bench to Bedside. Oxford : Blackwell Futura, 2005.
2. Priori SG, Napolitano C, Gasparini M, Pappone C, Della BP, Giordano U, Bloise R, Giustetto C, De Nardis R, Grillo M, Ronchetti E, Faggiano G, Nastoli J : Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation 2002 105 : 1342 1347.
3. Antzelevitch C : The Brugada syndrome: Ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001 12 : 268 272.
4. Balser JR : The cardiac sodium channel: Gating function and molecular pharmacology. J Mol Cell Cardiol 2001 33 : 599 613.
5. Tan H : Biophysical analysis of mutant sodium channels in Brugada syndrome. In : Antzelevitch C, Brugada P, Brugada J, Brugada R, eds. The Brugada Syndrome: From Bench to Bedside. Oxford : Blackwell Futura, 2004, pp. 26 41.
6. Brugada R : Brugada syndrome: Role of genetics in clinical practice. In : Antzelevitch C, Brugada P, Brugada J, Brugada R, eds. The Brugada Syndrome: From Bench to Bedside. Oxford : Blackwell Futura, 2004, pp. 130 139.
7. Yan GX, Antzelevitch C : Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation 1999 100 : 1660 1666.
8. Di Diego JM, Cordeiro JM, Goodrow RJ, Fish JM, Zygmunt AC, Perez GJ, Scornik FS, Antzelevitch C : Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation 2002 106 : 2004 2011.
9. Fish JM, Antzelevitch C : Role of sodium and calcium channel block in unmasking the Brugada syndrome. Heart Rhythm 2004 1 : 210 217.
10. Kurita T, Shimizu W, Inagaki M, Suyama K, Taguchi A, Satomi K, Aihara N, Kamakura S, Kobayashi J, Kosakai Y : The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 2002 40 : 330 334.
11. Fish JM, Welchons D, Kim YS, Lee SH, Ho WK, Antzelevitch C : DMLSB, an extract of salvia miliorrhiza, as a potential therapy for Brugada syndrome. Circulation 2006 113 : 1393 1400.
12. Aiba T, Shimizu W, Hidaka I, Uemura K, Noda T, Zheng C, Kamiya A, Inagaki M, Sugimachi M, Sunagawa K : Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: High-resolution optical mapping study. J Am Coll Cardiol 2006 47 : 2074 2085.
13. Nishizaki M, Fujii H, Sakurada H, Kimura A, Hiraoka M : Spontaneous T wave alternans in a patient with brugada syndrome-responses to intravenous administration of class I antiarrhythmic drug, glucose tolerance test, and atrial pacing. J Cardiovasc Electrophysiol 2005 16 : 217 220.
14. Tada H, Nogami A, Shimizu W, Naito S, Nakatsugawa M, Oshima S, Taniguchi K : ST segment and T wave alternans in a patient with Brugada syndrome. PACE 2000 23 : 413 415.
15. Chinushi M, Washizuka T, Okumura H, Aizawa Y : Intravenous administration of class I antiarrhythmic drugs induced T wave alternans in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2001 12 : 493 495.
16. Chinushi Y, Chinushi M, Toida T, Aizawa Y : Class I antiarrhythmic drug and coronary vasospasm-induced T wave alternans and ventricular tachyarrhythmia in a patient with Brugada syndrome and vasospastic angina. J Cardiovasc Electrophysiol 2002 13 : 191 194.
17. Takagi M, Doi A, Takeuchi K, Yoshikawa J : Pilsicanide-induced marked T wave alternans and ventricular fibrillation in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002 13 : 837.
18. Ohkubo K, Watanabe I, Okumura Y, Yamada T, Masaki R, Kofune T, Oshikawa N, Kasamaki Y, Saito S, Ozawa Y, Kanmatsuse K : Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient. PACE 2003 26 : 1900 1903.
19. Morita H, Morita ST, Nagase S, Banba K, Nishii N, Tani Y, Watanabe A, Nakamura K, Kusano KF, Emori T, Matsubara H, Hina K, Kita T, Ohe T : Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome. J Am Coll Cardiol 2003 42 : 1624 1631.
20. Morita H, Nagase S, Kusano K, Ohe T : Spontaneous T wave alternans and premature ventricular contractions during febrile illness in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002 13 : 816 818.
21. Morita H, Zipes DP, Lopshire J, Morita ST, Wu J : T wave alternans in an in vitro canine tissue model of Brugada syndrome. Am J Physiol Heart Circ Physiol 2006 291 : H421 H428.
22. Yan GX, Antzelevitch C : Cellular basis for the normal T wave and the electrocardiographic manifestations of the long QT syndrome. Circulation 1998 98 : 1928 1936.
23. Di Diego JM, Sun ZQ, Antzelevitch C : Ito and action potential notch are smaller in left vs. right canine ventricular epicardium. Am J Physiol 1996 271 : H548 H561.
24. Krishnan SC, Antzelevitch C : Flecainide-induced arrhythmia in canine ventricular epicardium. Phase 2 Reentry? Circulation 1993 87 : 562 572.
25. Di Diego JM, Antzelevitch C : Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissues. Does activation of ATP-regulated potassium current promote phase 2 reentry? Circulation 1993 88 : 1177 1189.
26. Di Diego JM, Antzelevitch C : High [Ca2+]-induced electrical heterogeneity and extrasystolic activity in isolated canine ventricular epicardium. Phase 2 reentry. Circulation 1994 89 : 1839 1850.
27. Yan GX, Antzelevitch C : Cellular basis for the electrocardiographic J wave. Circulation 1996 93 : 372 379.
28. Fish JM, Antzelevitch C : Link between hypothermia and the Brugada syndrome. J Cardiovasc Electrophysiol 2004 15 : 942 944.
29. Shimizu W : Acquired forms of Brugada syndrome. In : Antzelevitch C, Brugada P, Brugada J, Brugada R, eds. The Brugada Syndrome: From Bench to Bedside. Oxford : Blackwell Futura 2004, pp. 166 177.
30. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A : Brugada Syndrome. Report of the Second Consensus Conference. Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005 111 : 659 670.
31. Antzelevitch C, Fish JM : Therapy for the Brugada Syndrome. In : Kass R, Clancy CE, eds. Handbook of Experimental Pharmacology. New York : Springer-Verlag, 2006, pp. 305 330.
32. Di Diego JM, Antzelevitch C : Cellular basis for ST-segment changes observed during ischemia. J Electrocardiol 2003 36 Suppl : 1 5.
33. Yan GX, Joshi A, Guo D, Hlaing T, Martin J, Xu X, Kowey PR : Phase 2 reentry as a trigger to initiate ventricular fibrillation during early acute myocardial ischemia. Circulation 2004 110 : 1036 1041.
34. Oe H, Taniura T, Ohgitani N : A case of severe verapamil overdose. Jpn Circ J 1998 62 : 72 76.
35. Antzelevitch C : Modulation of transmural repolarization. Ann N Y Acad Sci 2005 1047 : 314 323.